Brief: Collegium Reports Second Quarter 2022 Financial Results
Aug 4 (Reuters) - Collegium Pharmaceutical Inc COLL.O :
* COLLEGIUM REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
* Q2 REVENUE $123.5 MILLION
* QTRLY LOSS PER SHARE $0.15
* SEES FY TOTAL ADJUSTED EBITDA OF $245.0 MILLION TO $255.0 MILLION
Source text for Eikon: ID:nGNX7Bfls8
Further company coverage: COLL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Collegium Pharmaceutical
See all newsBrief: Collegium Pharmaceutical - Co And Grünenthal Enter Settlement Agreement On Oct 15, 2026 - SEC Filing
Brief: Collegium Announces $50 Million Accelerated Share Repurchase Program
U.S. RESEARCH ROUNDUP-Airbnb, Expedia Group, Parker-Hannifin
Collegium Pharmaceutical Inc reports results for the quarter ended June 30 - Earnings Summary
Collegium Q2 revenue rises 6%